Actinium Pharmaceuticals
ATNM
#9342
Rank
ยฃ36.42 M
Marketcap
ยฃ1.17
Share price
5.76%
Change (1 day)
-66.01%
Change (1 year)

Revenue for Actinium Pharmaceuticals (ATNM)

Revenue in 2024 (TTM): ยฃ0.06 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.06 Million. In 2023 the company made a revenue of ยฃ0.06 Million a decrease over the revenue in the year 2022 that were of ยฃ0.85 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Actinium Pharmaceuticals from 2007 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.06 M0%
2023 ยฃ0.06 M-92.53%
2022 ยฃ0.85 M0.46%
2021 ยฃ0.84 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A
2008 N/A
2007 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ1.51 M 2,259.26%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.18 B 3,398,429.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.36 B 562,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA